SIGA's logo.
Ticker Symbol: SIGA

SIGA Technologies Inc

$7.75 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001010086

Company Profile

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Its lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the US maintains a stockpile of 1.7 million oral courses in the Strategic National Stockpile under Project BioShield. The oral formulation of TPOXX was approved by the FDA for the treatment of smallpox on July 13, 2018. In September 2018, SIGA signed a contract with Biomedical Advanced Research and Development Authority (BARDA) for additional procurement and development related to both oral and intravenous formulations of TPOXX.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 31 East 62nd Street
Website: www.siga.com
CEO: Phillip Louis Gomez III
Tags:
  • Health Technology
  • Pharmaceuticals: Other
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $5.22
Change: - ( 0.00%)
Days Range: $5.13 - $5.25
Beta: 1.22
52wk. High: $8.71
52wk. Low: $4.22
Ytd. Change -16.90%
50 Day Moving Average: $4.98
200 Day Moving Average: $5.14
Shares Outstanding: 71082944

Valuation

Market Cap: 37.1B
PE Ratio: 13.32
EPS (TTM): 0.3919

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A